HRMY - Harmony Biosciences Holdings - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HRMY is currently covered by 10 analysts with an average price target of $44.65. This is a potential upside of $6.15 (15.97%) from yesterday's end of day stock price of $38.5.

Harmony Biosciences Holdings's activity chart (see below) currently has 193 price targets and 175 ratings on display. The stock rating distribution of HRMY is 78.57% BUY, 17.86% HOLD and 3.57% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 34.93% with an average time for these price targets to be met of 121.52 days.

Highest price target for HRMY is $72, Lowest price target is $28, average price target is $44.65.

Most recent stock forecast was given by AMI FADIA from NEEDHAM on 19-Oct-2026. First documented stock forecast 11-Sep-2020.

Best performing analysts who are covering HRMY - Harmony Biosciences Holdings:

David Amsellem Ami Fadia Chris Howerton Graig Suvannavejh Danielle Brill Corinne Jenkins

Currently out of the existing stock ratings of HRMY, 22 are a BUY (78.57%), 5 are a HOLD (17.86%), 1 are a SELL (3.57%).

Split History since 2000:

12/5/00 3 for 1

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 22-Sep-2021

$50

$13.87 (38.39%)

$50

11 days ago
(19-Oct-2026)

6/36 (16.67%)

$12.46 (33.19%)

319

Buy Since 07-Sep-2023

$55

$18.87 (52.23%)

$54

15 days ago
(15-Oct-2026)

0/3 (0%)

$16.73 (43.72%)

Hold Since 08-May-2026

$34

$-2.13 (-5.90%)

$29

2 months 25 days ago
(05-Aug-2026)

8/14 (57.14%)

$-4.24 (-11.09%)

148

Buy Since 01-Sep-2022

$51

$14.87 (41.16%)

$46

2 months 29 days ago
(31-Jul-2026)

17/33 (51.52%)

$15.76 (44.72%)

276

Buy Since 17-Dec-2024

$55

$18.87 (52.23%)

$55

3 months 14 days ago
(16-Jul-2026)

0/16 (0%)

$21.47 (64.03%)

Show more analysts

Please expand the browser size to see the chart

What is HRMY (Harmony Biosciences Holdings) average time for price targets to be met?

On average it took 122 days for the stock forecasts to be reached, with an average price target met ratio of 34.93%.

Which analyst most recently updated their price target on HRMY (Harmony Biosciences Holdings)?

Ami Fadia

Which analyst has the most public recommendations on HRMY (Harmony Biosciences Holdings)?

Ami Fadia works at NEEDHAM and has 52 price targets and 47 ratings on HRMY

Which analyst is the currently most bullish on HRMY (Harmony Biosciences Holdings)?

Andreas Argyrides with the highest potential upside of $35.87

Which analyst is the currently most reserved on HRMY (Harmony Biosciences Holdings)?

Jason Gerberry with the lowest potential downside of -$8.13
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?